Adaptive Biotechnologies — lobbying record — Receipts Report
Client
Lobbying client · LD-2 disclosures
Adaptive Biotechnologies
Washington
29 filings from 3 registrants · 2015–2024 · latest filed Jan 16, 2025
Reported on its behalf
$2M
every LD-2 on file
Its own filed spend
$1M
lobbying for itself
Fees to outside firms
$1M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: adaptive-biotechnologies.
fees reported
›
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
8 filings
$540K on those filings
Medical/Disease Research/Clinical Labs
MED
3 filings
$30K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
117th Congress
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
S. 3404117th CongressA bill to provide the consent of Congress to an amendment to the Constitution of the State of New Mexico.5 filingsthrough 2022
H.R. 6102116th CongressVALID Act of 20205 filingsthrough 2020
S. 3404116th CongressVALID Act of 20205 filingsthrough 2020
H.R. 2369118th CongressVALID Act of 20234 filingsthrough 2023
H.R. 4502117th CongressLabor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 20224 filingsthrough 2022
H.R. 1946117th CongressMedicare Multi-Cancer Early Detection Screening Coverage Act of 20213 filingsthrough 2022
S. 1873117th CongressMedicare Multi-Cancer Early Detection Screening Coverage Act of 20213 filingsthrough 2022
S. 4348117th CongressFDASLA Act of 20223 filingsthrough 2022
S. 2085118th CongressMedicare Multi-Cancer Early Detection Screening Coverage Act2 filingsthrough 2023
H.R. 8239117th CongressAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20232 filingsthrough 2022
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Arnold & Porter Kaye Scholer LLP
Covered position: Health Counsel, Rep. Burgess (2019-2020); Intern, House Energy & Commerce Committee (2019)
15 filingsthrough 2023
Bobby McmillinArnold & Porter Kaye Scholer LLPCovered position: General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-2013); Press Intern, Sen. Chambliss (2007)11 filingsthrough 2023
Peter Eric DuyshartArnold & Porter Kaye Scholer LLPCovered position: Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015)9 filingsthrough 2023
Cj MahlerArnold & Porter Kaye Scholer LLPCovered position: Intern, Sen. Corker (2016); Intern, Senate Foreign Relations Committee (2017); Intern, Senate Health, Education, Labor, and Pensions Committee (2018)8 filingsthrough 2021
